Position in GMAB
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$237,474,771
-$18,943,536 QoQ
Shares Held
8,644,877
-9.5% QoQ
Ownership
1.41%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#3
of 289 holders
Holding Since
Jun 2020
20 quarters on record
Voting authority
Sole 96%
Shared 0%
None 4%
Common Shares in GMAB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ALLIANCEBERNSTEIN L.P. holds $5,177,847,011 across 257 Biotechnology names. GMAB ranks #3 (4.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,019,315 | $1,499,784,339 | |
| 2 | ARGX |
Argenx SE
|
395,661 | $367,082,405 | |
| 3 | GMAB |
Genmab A/S
This page
|
8,644,877 | $237,474,771 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
292,338 | $182,284,436 | |
| 5 | TECH |
BIO-TECHNE Corp
|
2,002,026 | $141,443,136 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
1,696,538 | $132,788,029 | |
| 7 | KYMR |
Kymera Therapeutics, Inc.
|
981,521 | $112,551,013 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,453,504 | $108,256,977 |
All Filings in GMAB
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $237,474,771 | 8,644,877 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $256,418,307 | 9,557,149 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $335,014,495 | 10,877,094 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $335,956,511 | 10,953,913 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $220,284,667 | 10,662,375 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $288,318,593 | 14,725,158 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $311,698,124 | 14,935,224 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $369,019,385 | 15,136,152 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $382,926,894 | 15,237,839 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $456,257,518 | 15,254,347 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $497,165,998 | 15,614,510 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $335,601,421 | 9,515,209 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $311,209,763 | 8,187,576 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $255,509,119 | 6,766,661 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $268,503,490 | 6,335,618 | Shares | Defined | 2023-02-15 | |
| 2022-09-30 | $185,694,981 | 5,779,489 | Shares | Defined | 2022-11-15 | |
| 2021-09-30 | $5,850,031 | 133,868 | Shares | Defined | 2021-11-10 | |
| 2021-06-30 | $5,154,379 | 126,240 | Shares | Defined | 2021-07-30 | |
| 2020-09-30 | $11,320,141 | 309,209 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $6,574,354 | 193,991 | Shares | Defined | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||